Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Retained Earnings (2012 - 2026)

Kamada's (KMDA) quarterly Retained Earnings came in at $268.4 million in Q2 2026, little changed on a YoY basis from $268.2 million in Q2 2025, and little changed quarter-over-quarter from $268.4 million in Q1 2026.

Analysis

Kamada (KMDA) Retained Earnings (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Retained Earnings for 15 consecutive years, with $268.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings changed 0.06% year-over-year to $268.4 million; the trailing twelve-month figure through Jun 2026 stood at $268.4 million (changed 0.06% YoY), and the FY2025 full-year result was $268.3 million, up 0.51% from the prior year.
  • Retained Earnings held at $268.4 million in Q2 2026 per KMDA's latest filing, from $268.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $268.4 million in Q2 2026 and bottomed at -$45.3 million in Q3 2023.
  • Historically, Retained Earnings has averaged $231.1 million across 5 years, with a median of $266.2 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings sank 121.52% in 2023, then jumped 689.04% in 2024.
  • Over 5 years, Retained Earnings stood at $210.5 million in 2022, then rose by 26.3% to $265.8 million in 2023, then grew by 0.41% to $266.9 million in 2024, then advanced by 0.51% to $268.3 million in 2025, then gained by 0.05% to $268.4 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $268.4 million, $268.4 million, and $268.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 558.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 5.13 Bn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn 268.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 268.40 Mn
Mar 31, 2026 268.36 Mn
Dec 31, 2025 268.28 Mn
Sep 30, 2025 268.22 Mn
Jun 30, 2025 268.24 Mn
Mar 31, 2025 268.16 Mn
Dec 31, 2024 266.93 Mn
Sep 30, 2024 266.59 Mn
Jun 30, 2024 266.31 Mn
Mar 31, 2024 266.18 Mn
Dec 31, 2023 265.85 Mn
Sep 30, 2023 -45.26 Mn
Jun 30, 2023 210.73 Mn
Mar 31, 2023 210.67 Mn
Dec 31, 2022 210.50 Mn
Sep 30, 2022 210.36 Mn
Jun 30, 2022 210.32 Mn
Mar 31, 2022 210.27 Mn
Dec 31, 2021 210.20 Mn
Sep 30, 2021 210.01 Mn